• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

GSK189254A Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5764323

GSK189254A (GSK189254) is a new, potent and specific histamine H receptor antagonist (pKi values: 9.59-9.90 and 8.51-9.17 for human and rat H3). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
GSK189254A, Inhibitor
Full Product Name
GSK189254A
Product Gene Name
Product Synonym Names
GSK189254
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
351.44
Solubility
DMSO: 24mg/mL (68.29mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C21H25N3O2
SMILES
O=C(NC)C(C=N1)=CC=C1OC2=CC(CC3)=C(C=C2)CCN3C4CCC4
CAS Number
720690-73-3
In Vitro
GSK189254 has a high affinity for both recombinant H3 receptors expressed in HEK-293-MSR-II cells and native H3 receptors expressed in the cerebral cortex of several species. GSK189254 generally exhibits a higher affinity for human and pig H3 receptors compared with mouse, rat, and dog H3 receptors. GSK189254 may have therapeutic potential for the symptomatic treatment of dementia in Alzheimer's disease and other cognitive disorders [1].

Product References and Citations for GSK189254A, inhibitor

Medhurst AD, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45.
Medhurst AD, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45.
Guo RX, et al. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol. 2009 May;157(1):104-17.
Guo RX, et al. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol. 2009 May;157(1):104-17.

Other Notes

Small volumes of GSK189254A, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for GSK189254A purchase

MBS5764323 is an inhibitor targeting GSK189254A.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000